Strategic CDMO Partnership with A Global Pharmaceutical Company - Gland Pharma Ltd

Code BSE: 543245 NSE:

Gland Pharma announces Strategic CDMO Partnership with A Global Pharmaceutical Company The partnership establishes Gland Pharma as an integrated end-to-end partner supporting multiple products across various stages of the product lifecycle, including both commercially marketed products and pipeline products under development. The collaboration follows a full-service CDMO model encompassing technology transfer, process development, scale-up, validation, commercial manufacturing, and long-term supply of sterile injectable products